Loading clinical trials...
Loading clinical trials...
This study investigates the feasibility of FLT-PET to improve the diagnosis of relapse in patients with irradiated lung cancer in comparison with FDG-PET/CT.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rigshospitalet, Denmark
NCT07668037 · Non-Small Cell Carcinoma of Lung, Immunotherapy, and more
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
NCT06529822 · Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma, and more
NCT07164170 · Non-Small Cell Lung Cancer
NCT06364917 · Non Small Cell Lung Cancer
Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Copenhagen
Dept. Respiratory Medicine, Bispebjerg University Hospital
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions